Natural killer cell activation related to clinical outcome of COVID-19
Christopher Maucourant, Iva Filipovic, Andrea Ponzetta, Soo Aleman, Martin Cornillet, Laura Hertwig, Benedikt Strunz, Antonio Lentini, Björn Reinius, Demi Brownlie, Angelica Cuapio Gomez, Eivind Heggernes Ask, Ryan M. Hull, Alvaro Haroun-Izquierdo, Marie Schaffer, Jonas Klingström, Elin Folkesson, Marcus Buggert, Johan K. Sandberg, Lars I. Eriksson, Olav Rooyackers, Hans-Gustaf Ljunggren, Karl-Johan Malmberg, Jakob Michaëlsson, Nicole Marquardt, Quirin Hammer, Kristoffer Strålin, Niklas K. Björkström, Karolinska COVID-19 Study Group
doi: https://doi.org/10.1101/2020.07.07.20148478
Christopher Maucourant
1Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Iva Filipovic
1Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Andrea Ponzetta
1Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Soo Aleman
2Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden
Martin Cornillet
1Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Laura Hertwig
1Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Benedikt Strunz
1Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Antonio Lentini
3Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
Björn Reinius
3Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
Demi Brownlie
1Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Angelica Cuapio Gomez
1Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Eivind Heggernes Ask
4Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway
Ryan M. Hull
5SciLifeLab, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Solna, Sweden
Alvaro Haroun-Izquierdo
1Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Marie Schaffer
1Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Jonas Klingström
1Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Elin Folkesson
2Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden
Marcus Buggert
1Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Johan K. Sandberg
1Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Lars I. Eriksson
6Department of Physiology and Pharmacology, Section for Anesthesiology and Intensive Care, Karolinska Institutet, Stockholm, Sweden
8Function Perioperative Medicine and Intensive Care, Karolinska University Hospital, Stockholm, Sweden
Olav Rooyackers
7Department Clinical Interventions and Technology CLINTEC, Division for Anesthesiology and Intensive Care, Karolinska Institutet, Stockholm, Sweden
8Function Perioperative Medicine and Intensive Care, Karolinska University Hospital, Stockholm, Sweden
Hans-Gustaf Ljunggren
1Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Karl-Johan Malmberg
1Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
3Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
9The KG Jebsen Center for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway
Jakob Michaëlsson
1Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Nicole Marquardt
1Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Quirin Hammer
1Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Kristoffer Strålin
2Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden
Niklas K. Björkström
1Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
Curated flow cytometry data is available for exploration via the Karolinska COVID-19 Immune Atlas (homepage currently under construction).
Posted July 10, 2020.
Natural killer cell activation related to clinical outcome of COVID-19
Christopher Maucourant, Iva Filipovic, Andrea Ponzetta, Soo Aleman, Martin Cornillet, Laura Hertwig, Benedikt Strunz, Antonio Lentini, Björn Reinius, Demi Brownlie, Angelica Cuapio Gomez, Eivind Heggernes Ask, Ryan M. Hull, Alvaro Haroun-Izquierdo, Marie Schaffer, Jonas Klingström, Elin Folkesson, Marcus Buggert, Johan K. Sandberg, Lars I. Eriksson, Olav Rooyackers, Hans-Gustaf Ljunggren, Karl-Johan Malmberg, Jakob Michaëlsson, Nicole Marquardt, Quirin Hammer, Kristoffer Strålin, Niklas K. Björkström, Karolinska COVID-19 Study Group
medRxiv 2020.07.07.20148478; doi: https://doi.org/10.1101/2020.07.07.20148478
Natural killer cell activation related to clinical outcome of COVID-19
Christopher Maucourant, Iva Filipovic, Andrea Ponzetta, Soo Aleman, Martin Cornillet, Laura Hertwig, Benedikt Strunz, Antonio Lentini, Björn Reinius, Demi Brownlie, Angelica Cuapio Gomez, Eivind Heggernes Ask, Ryan M. Hull, Alvaro Haroun-Izquierdo, Marie Schaffer, Jonas Klingström, Elin Folkesson, Marcus Buggert, Johan K. Sandberg, Lars I. Eriksson, Olav Rooyackers, Hans-Gustaf Ljunggren, Karl-Johan Malmberg, Jakob Michaëlsson, Nicole Marquardt, Quirin Hammer, Kristoffer Strålin, Niklas K. Björkström, Karolinska COVID-19 Study Group
medRxiv 2020.07.07.20148478; doi: https://doi.org/10.1101/2020.07.07.20148478
Subject Area
Subject Areas
- Addiction Medicine (343)
- Allergy and Immunology (666)
- Anesthesia (180)
- Cardiovascular Medicine (2630)
- Dermatology (222)
- Emergency Medicine (397)
- Epidemiology (12181)
- Forensic Medicine (10)
- Gastroenterology (756)
- Genetic and Genomic Medicine (4070)
- Geriatric Medicine (387)
- Health Economics (678)
- Health Informatics (2627)
- Health Policy (998)
- Hematology (361)
- HIV/AIDS (845)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (431)
- Neurology (3840)
- Nursing (209)
- Nutrition (571)
- Oncology (2011)
- Ophthalmology (582)
- Orthopedics (239)
- Otolaryngology (304)
- Pain Medicine (250)
- Palliative Medicine (74)
- Pathology (471)
- Pediatrics (1109)
- Primary Care Research (448)
- Public and Global Health (6504)
- Radiology and Imaging (1390)
- Respiratory Medicine (869)
- Rheumatology (401)
- Sports Medicine (341)
- Surgery (441)
- Toxicology (52)
- Transplantation (185)
- Urology (165)